Publications by authors named "Rodrigo G Taboada"

Claim this Profile
A
Alkylating-induced hypermutation in pancreatic neuroendocrine tumours.
Rodrigo G Taboada, Giovana T Torrezan, Rachel P Riechelmann

BMJ Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic Ductal Adenocarcinoma with Medullary Features and a Complete Pathological Response After Neoadjuvant FOLFIRINOX: A Case Report and Literature Review.
Rodrigo Gomes Taboada, Maria Fernanda Arruda Almeida, Karina Miranda Santiago, Dirce Maria Carraro, Warley Abreu Nunes

J Gastrointest Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Efficacy of a Lower Dose of Everolimus in Patients with Advanced Neuroendocrine Tumors.
Rodrigo G Taboada, Angelo B Brito, Ana Luiza Silva, Rui F Weschenfelder, Rachel P Riechelmann

Cancers (Basel)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyrosine kinase inhibitors in patients with neuroendocrine neoplasms: a systematic literature review.
Rodrigo G Taboada, Felicia P Cavalher, Juliana F Rego, Rachel P Riechelmann

Ther Adv Med Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival trends in gastric cancer in Brazil: real-life data from a large cancer center.
Angelo Borsarelli Carvalho Brito, Tiago Cordeiro Felismino, Diego Rodrigues Mendonca E Silva, Maria Paula Curado, Lais Corsino Durant, Rodrigo Gomes Taboada

Ecancermedicalscience· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiating high-grade neuroendocrine neoplasms.
Rodrigo Gomes Taboada, Rachel P Riechelmann

Nat Rev Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HORMONET: a phase II trial of tamoxifen for estrogen/progesterone receptor-positive neuroendocrine tumors.
Milton J Barros, Jonathan Strosberg, Taymeyah Al-Toubah, Victor Hugo F de Jesus, Lais Durant, Rodrigo G Taboada

Ther Adv Med Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy Sequencing in Patients With Advanced Neuroendocrine Neoplasms.
Rachel P Riechelmann, Rodrigo G Taboada, Victor Hugo F de Jesus, Michael Iglesia, Nikolaos A Trikalinos

Am Soc Clin Oncol Educ Book· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus-Induced Pneumonitis in Patients with Neuroendocrine Neoplasms: Real-World Study on Risk Factors and Outcomes.
Rodrigo G Taboada, Rachel P Riechelmann, Carine Mauro, Milton Barros, Richard A Hubner

Oncologist· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the Morphological Subtype of Extra-Pulmonary Neuroendocrine Carcinoma Clinically Relevant?
Melissa Frizziero, Alice Durand, Rodrigo G Taboada, Elisa Zaninotto, Claudio Luchini

Cancers (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease-Free Survival and Time to Complete Response After Definitive Chemoradiotherapy for Squamous-Cell Carcinoma of the Anus According to HIV Infection.
Marcos Pedro Guedes Camandaroba, Soledad Iseas, Caroline Oliveira, Rodrigo G Taboada, Mariana P Xerfan

Clin Colorectal Cancer· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis